Related references
Note: Only part of the references are listed.Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Tobias Lanz et al.
NATURE (2022)
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
Panos Stathopoulos et al.
NEUROTHERAPEUTICS (2022)
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies
Nicola De Stefano et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study
Leoni Rolfes et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
Klaus Schmierer et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients
M. C. Kowarik et al.
NEUROTHERAPEUTICS (2021)
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study
Anat Achiron et al.
JOURNAL OF NEUROIMMUNOLOGY (2021)
Immunomodulatory Effects Associated with Cladribine Treatment
Nicolas Fissolo et al.
CELLS (2021)
Next Generation Sequencing of Cerebrospinal Fluid B Cell Repertoires in Multiple Sclerosis and Other Neuro-Inflammatory Diseases-A Comprehensive Review
Christoph Ruschil et al.
DIAGNOSTICS (2021)
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies
Maria T. Cencioni et al.
NATURE REVIEWS NEUROLOGY (2021)
The nf-core framework for community-curated bioinformatics pipelines
Philip A. Ewels et al.
NATURE BIOTECHNOLOGY (2020)
Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D
Susan A. Kennedy et al.
NATURE COMMUNICATIONS (2020)
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab
C. L. Kemmerer et al.
PLOS ONE (2020)
The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
Kottil Rammohan et al.
DRUGS (2020)
Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses
Christoph Ruschil et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis
Giancarlo Comi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Analysis of the B cell receptor repertoire in six immune-mediated diseases
R. J. M. Bashford-Rogers et al.
NATURE (2019)
B cells in autoimmune and neurodegenerative central nervous system diseases
Joseph J. Sabatino et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers
Olaf Stuve et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
Bryan Ceronie et al.
JOURNAL OF NEUROLOGY (2018)
Cladribine tablets added to IFN-β in active relapsing MS The ONWARD study
Xavier Montalban et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing
Jason A. Vander Heiden et al.
JOURNAL OF IMMUNOLOGY (2017)
Nextflow enables reproducible computational workflows
Paolo Di Tommaso et al.
NATURE BIOTECHNOLOGY (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
CNS Aquaporin-4-specific B cells connect with multiple B-cell compartments in neuromyelitis optica spectrum disorder
Markus C. Kowarik et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
David Baker et al.
EBIOMEDICINE (2017)
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients
Erica L. Eggers et al.
JCI INSIGHT (2017)
The MaxQuant computational platform for mass spectrometry-based shotgun proteomics
Stefka Tyanova et al.
NATURE PROTOCOLS (2016)
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
Mika Komori et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data
Namita T. Gupta et al.
BIOINFORMATICS (2015)
pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires
Jason A. Vander Heiden et al.
BIOINFORMATICS (2014)
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
Thomas P. Leist et al.
LANCET NEUROLOGY (2014)
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
Arumugam Palanichamy et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
Joel N. H. Stern et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis
Krystyna Mitosek-Szewczyk et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
IgBLAST: an immunoglobulin variable domain sequence analysis tool
Jian Ye et al.
NUCLEIC ACIDS RESEARCH (2013)
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Gavin Giovannoni et al.
LANCET NEUROLOGY (2011)
Widespread RNA and DNA Sequence Differences in the Human Transcriptome
Mingyao Li et al.
SCIENCE (2011)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
E Meinl et al.
ANNALS OF NEUROLOGY (2006)
Share Paper
